Article
Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium.
Journal of clinical microbiology - 1 Jan 2012
Wong Anita A, Fuller Jeff, Pabbaraju Kanti, Wong Sallene, Zahariadis George
Abstract excerpt
Clinical cervical cytology specimens (n = 466) collected in PreservCyt (Hologic Inc.) were used to evaluate the agreement between Hybrid Capture 2 (hc2; Qiagen) and cobas 4800 (c4800; Roche Molecular Diagnostics) for the detection of high-risk human papillomavirus (HR HPV) genotype infections. The agreement between the two assays was 93.8% (kappa = 0.87; 95% confidence interval, 0.828 to 0.918), with 186 and 251...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
